Inspiration 360
Core to our company is a holistic vision of health, which includes: full healthcare processes, diagnostics, and treatments as a tool to improve and support patient care.
We empower doctors with disruptive tools and technologies that help them in their clinical and diagnostic processes and with dispensing medicine. This is the future of medical treatments.
We’re disrupting traditional solutions by analysing and reversing clinical programming processes. We started with pharmacological processes, because our team understands that prescriptions and drugs are the basis upon which physicians build their therapeutic treatments of patients.
We use innovative technologies that precisely define a patient’s pathological status and scenario precisely. From there, solutions are entirely determined by the different medical societies and existing clinical databases. Only the best therapeutic strategies that are supported with extensive clinical data are included in our knowledge base and adapted to the patient’s conditions are used. This guarantees the best solution to a patient’s health concern.
Artificial intelligence is used to enhance the patient’s treatment. The use of AI and algorithms mean that each patient’s individual case is being analyzed, including their clinical history.
We greatly enhance the patient’s clinical data with genomic information, which is adapted to their unique metabolic processes. This is key to determining the best drug for each patient. Ultimately, enhancing all medical processes and further enabling successful outcomes through the treatments offered.
With a holistic approach to medicine, we are interested in generating and furthering personalized medicine, our technology is founded and developed on this principle.
As our technology is intelligent, specifically AI, we are always developing and refining our offerings to better serve and support doctors and patients. New applications and services will allow us to advance therapeutic processes to treat diseases and most importantly patients more effectively.
Our extensive pharmaceutical knowledge enables us to identify new components involved in the pathogenesis of disease. Our system works to identify new therapeutic targets based upon the patient’s conditions and ultimately offer the best available treatment for each patient.
Pharmacotherapeutic databases
Marketed August 2018
App Pharma
Marketed July 2021
Smart Clinical Dashboard for EHRs
In prototype TRL5: Q2 2022 / Ending: Q4 2022
Smart Clinical Dashboard for HPMSs
In prototype TRL5: Q2 2022 / Ending: Q4 2022
Smart Clinical Dashboard for Pharmacies
In prototype TRL5: Q2 2022 / Ending: Q4 2022
Healthcare professionals and pharmacists
Medical Workstations / POS at pharmacies
Smart Automated Telemedicine Platform
In prototype TRL5: Q2 2022 / Ending: Q4 2022
Smart COVID-19
In prototype TRL5: Q2 2022 / Ending: Q4 2022
Smart online Pharmacy
In prototype TRL5: Q2 2022 / Ending: Q4 2022
Smart Health Marketplace
In prototype TRL5: Q2 2022 / Ending: Q4 2022
Patients and customers
Personal devices
Technology
We use state-of-the-art Open technologies that allow us to offer disruptive tools, that allow solutions totally focused on the user with persistent, reactive operation, with total security of operation, privacy and evolution.
Security
Safety in clinical processes is our first premise in the services we offer, adopting the standards that allow us to structure, standardize and secure all the processes according to the most demanding international regulations.
Roadmap
Our medical solutions for healthcare:
We already have a deployment plan with many of the technologies and knowledge engines in place.
Our financial forecast is based on our deployment plan with the tools and platforms we already have in place as well as planned modules.
Once our core applications for intelligent health management are deployed, we will offer virtual training for online purchasing health treatments and the dispensing of pharmaceuticals.
We believe the future of our disruptive applications is bright, with our core focus being to further empower medical, paramedical and pharmaceutical professionals with advanced user assistance interfaces with total security while also supporting complete health in our patients.
The use of avatars and AI-powered virtualization technologies will be one of the following milestones to be implemented in healthcare, and our applications are ready for it.
- AI-Emergency call
- AI-Electronic medical record
- Drug AI-Discovery
- Firmware to control a new generation of medical devices
Our solutions
App Pharma
- To view all the characteristics of the drugs and medications that are marketed in Spain in a consolidated and structured way.
- Currently used by over 12 million patients across three separate contracts.
Smart Clinical Dashboard for EHRs
- Adds expert clinical decision capabilities to any EHR
- Advanced Interactive AI-Doctor engine. Ultra-fast and accurate response. Works as a real doctor
- All medical specialities. All clinical procedures
Smart Pharma Dashboard for HPMSs
- Adds expert pharmacotherapeutic and pharmacovigilance decision capabilities to any HPMS
- Advanced Interactive AI-Pharmacist engine.
- Global pharmacological checking.
Smart Pharma Dashboard for Pharmacies
- Adds expert drug prescription checking to any Pharmacy POS system
- Advanced Interactive AI-Pharmacist engine. Ultra-fast and accurate response.
- Works as a real pharmacist
AI-Professional Telemedicine
- Assisted by a virtual doctor
- Professional response, same as a face-to-face with a doctor.
- For all types of medical and health consultations
- To deal with medical emergencies and problems at work
Smart online Pharmacy
- Smart online pharmacy
- Packs, dispenses and delivers meds at home
- Advanced Interactive AI-Pharmacist engine. Ultra-fast and accurate response. Works as a real pharmacist
AI-Health Marketplace
- Assisted by a virtual doctor
- For the purchase of medical, health and wellness treatments
- For patients around the world
- For all medical specialties
- To access the catalogue of best available technologies
Key projects
*data year 2020
Autonomous Region of La Rioja
La Rioja is the smallest of the seventeen autonomous communities in Spain, with a GDP of €8,129 million, 316,197 inhabitants and an area of 5,045 km2.
- It makes 63.6% of public health spending on hospital and specialized services of the total medical spending of the community.
- It makes 15.6% of public health expenditure in pharmacy of the total medical expenditure of the community.
- Medical expenditure per inhabitant of €483 million
- Pharmacy spending of €75 million
- €1,535 of medical expenses per inhabitant
Autonomous Region of Valencia
Valencia is the fourth autonomous community in Spain, with a GDP of €216.527 million, 5,045,885 inhabitants and an area of 23,255 km2.
- It makes 59.6% of public health spending on hospital and specialized services of the total medical spending of the community.
- It makes 18.5% of public health expenditure in pharmacy of the total medical expenditure of the community.
- Medical expenditure per inhabitant of €7,386 million
- Pharmacy spending of €1,369 million
- €1,477 of medical expenses per inhabitant
Autonomous Region of Madrid
Madrid is the third autonomous community in Spain, with a GDP of €216.527 million, 6,752,763 inhabitants and an area of 8,028 km2.
- It makes 69.4% of public health spending on hospital and specialized services of the total medical spending of the community.
- It makes 14.9% of public health expenditure in pharmacy of the total medical expenditure of the community.
- Medical expenditure per inhabitant of €8,962 million
- Pharmacy spending of €1,336 million
- €1,340 of medical expenses per inhabitant